July 1, 2015 | Natera's IPO is looming, with the offering coming as early as tonight.
Xconomy reports that in documents filed today with the SEC, the company raised its fundraising goal to $175 million. The company hopes to sell 10 million shares at $17-$18 each. The change cames the same day that an independent
analyst report predicted a market for reproductive health tests will be $1.7 billion by 2020.